The best indicator for Xcel Energy (XEL)
We backtested 20 indicators across daily, weekly and hourly charts on real Xcel Energy (XEL) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 20/50 Cross
On the weekly chart, this is the strongest risk-adjusted edge we found for Xcel Energy (XEL) over ~53.5 years — trailing buy-and-hold by 1.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 20/50 Cross ✓ | Weekly | 7.3% | 0.52 | -41.5% | 57.9% | 19 | -1.2% |
| 2 | EMA 50/200 Cross ✓ | Daily | 6.8% | 0.51 | -41.1% | 53.1% | 32 | -1.7% |
| 3 | SMA 50/200 Cross ✓ | Daily | 6.3% | 0.49 | -47.8% | 59.5% | 37 | -2.2% |
| 4 | Money Flow Index ✓ | Daily | 4.1% | 0.33 | -75.6% | 79.2% | 72 | -4.4% |
| 5 | Donchian Breakout ✓ | Weekly | 3.5% | 0.33 | -65.3% | 51.2% | 43 | -5.0% |
| 6 | RSI Trend (>50) ✓ | Weekly | 3.6% | 0.32 | -49.3% | 50.7% | 150 | -4.8% |
| 7 | WaveTrend (8/6/4) ✓ | Daily | 3.8% | 0.31 | -74.9% | 71.0% | 193 | -4.7% |
| 8 | EMA 20/50 Cross ✓ | Daily | 3.0% | 0.28 | -45.0% | 44.0% | 125 | -5.5% |
| 9 | MACD ✓ | Daily | 3.2% | 0.28 | -57.2% | 47.2% | 540 | -5.3% |
| 10 | Bollinger Mean-Reversion ✓ | Weekly | 2.6% | 0.27 | -69.0% | 83.8% | 37 | -5.9% |
| 11 | Stochastic ✓ | Weekly | 2.5% | 0.26 | -57.6% | 73.9% | 46 | -6.0% |
| 12 | ADX / DMI ✓ | Weekly | 2.1% | 0.25 | -37.7% | 53.6% | 84 | -6.4% |
| 13 | Williams %R ✓ | Weekly | 2.5% | 0.25 | -69.1% | 70.1% | 67 | -5.9% |
| 14 | CCI ✓ | Daily | 2.5% | 0.24 | -74.9% | 66.5% | 245 | -6.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Xcel Energy (XEL), EMA 20/50 Cross on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.